GT Biopharma, Inc. (GTBP)
0.5389
+0.04
(+8.54%)
USD |
NASDAQ |
Feb 06, 16:00
0.53
-0.01
(-1.65%)
After-Hours: 20:00
GT Biopharma EPS Diluted (Quarterly) : -0.8268 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | -0.0626 |
| Lyell Immunopharma, Inc. | -2.126 |
| Geron Corp. | -0.0276 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Crinetics Pharmaceuticals, Inc. | -1.381 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.114M |
| Total Expenses (Quarterly) | 3.114M |
| Enterprise Value | 3.112M |
| Earnings Yield | -630.0% |
| Normalized Earnings Yield | -690.41 |